Global Anticancer Drugs Market Professional Survey Report 2019
Table of Content
- 1.4.1 Research Process
- 1.4.2 Data Triangulation
- 1.4.3 Research Approach
- 1.4.4 Base Year
- 1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
- 1.5.2 Covid-19 Impact: Commodity Prices Indices
- 1.5.3 Covid-19 Impact: Global Major Government Policy
2 Global Anticancer Drugs Quarterly Market Size Analysis
- 2.1 Anticancer Drugs Business Impact Assessment - COVID-19
- 2.1.1 Global Anticancer Drugs Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
- 2.1.2 Global Anticancer Drugs Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
- 2.2 Global Anticancer Drugs Quarterly Market Size 2020-2021
- 2.3 COVID-19-Driven Market Dynamics and Factor Analysis
- 2.3.1 Drivers
- 2.3.2 Restraints
- 2.3.3 Opportunities
- 2.3.4 Challenges
3 Quarterly Competitive Assessment, 2020
- 3.1 Global Anticancer Drugs Quarterly Market Size by Manufacturers, 2019 VS 2020
- 3.2 Global Anticancer Drugs Factory Price by Manufacturers
- 3.3 Location of Key Manufacturers Anticancer Drugs Manufacturing Factories and Area Served
- 3.4 Date of Key Manufacturers Enter into Anticancer Drugs Market
- 3.5 Key Manufacturers Anticancer Drugs Product Offered
- 3.6 Mergers & Acquisitions, Expansion Plans
4 Impact of Covid-19 on Anticancer Drugs Segments, By Type
- 4.1 Introduction
- 1.4.1 Cytotoxic Drugs (Alkylating Agents, and Antimetabolites)
- 1.4.2 Targeted Drugs (Monoclonal Antibodies and Tyrosine Kinase Inhibitors)
- 1.4.3 Hormonal Drugs
- 4.2 By Type, Global Anticancer Drugs Market Size, 2019-2021
- 4.2.1 By Type, Global Anticancer Drugs Market Size by Type, 2020-2021
- 4.2.2 By Type, Global Anticancer Drugs Price, 2020-2021
5 Impact of Covid-19 on Anticancer Drugs Segments, By Application
- 5.1 Overview
- 5.5.1 Lung Cancer
- 5.5.2 Breast Cancer
- 5.5.3 Leukemia
- 5.5.4 Colorectal Cancer
- 5.2 By Application, Global Anticancer Drugs Market Size, 2019-2021
- 5.2.1 By Application, Global Anticancer Drugs Market Size by Application, 2019-2021
- 5.2.2 By Application, Global Anticancer Drugs Price, 2020-2021
6 Geographic Analysis
- 6.1 Introduction
- 6.2 North America
- 6.2.1 Macroeconomic Indicators of US
- 6.2.2 US
- 6.2.3 Canada
- 6.3 Europe
- 6.3.1 Macroeconomic Indicators of Europe
- 6.3.2 Germany
- 6.3.3 France
- 6.3.4 UK
- 6.3.5 Italy
- 6.4 Asia-Pacific
- 6.4.1 Macroeconomic Indicators of Asia-Pacific
- 6.4.2 China
- 6.4.3 Japan
- 6.4.4 South Korea
- 6.4.5 India
- 6.4.6 ASEAN
- 6.5 Rest of World
- 6.5.1 Latin America
- 6.5.2 Middle East and Africa
7 Company Profiles
- 7.1 F. Hoffmann-La Roche Ltd
- 7.1.1 F. Hoffmann-La Roche Ltd Business Overview
- 7.1.2 F. Hoffmann-La Roche Ltd Anticancer Drugs Quarterly Production and Revenue, 2020
- 7.1.3 F. Hoffmann-La Roche Ltd Anticancer Drugs Product Introduction
- 7.1.4 F. Hoffmann-La Roche Ltd Response to COVID-19 and Related Developments
- 7.2 Eli Lilly and Company
- 7.2.1 Eli Lilly and Company Business Overview
- 7.2.2 Eli Lilly and Company Anticancer Drugs Quarterly Production and Revenue, 2020
- 7.2.3 Eli Lilly and Company Anticancer Drugs Product Introduction
- 7.2.4 Eli Lilly and Company Response to COVID-19 and Related Developments
- 7.3 CELGENE CORPORATION
- 7.3.1 CELGENE CORPORATION Business Overview
- 7.3.2 CELGENE CORPORATION Anticancer Drugs Quarterly Production and Revenue, 2020
- 7.3.3 CELGENE CORPORATION Anticancer Drugs Product Introduction
- 7.3.4 CELGENE CORPORATION Response to COVID-19 and Related Developments
- 7.4 Novartis AG
- 7.4.1 Novartis AG Business Overview
- 7.4.2 Novartis AG Anticancer Drugs Quarterly Production and Revenue, 2020
- 7.4.3 Novartis AG Anticancer Drugs Product Introduction
- 7.4.4 Novartis AG Response to COVID-19 and Related Developments
- 7.5 Pfizer Inc
- 7.5.1 Pfizer Inc Business Overview
- 7.5.2 Pfizer Inc Anticancer Drugs Quarterly Production and Revenue, 2020
- 7.5.3 Pfizer Inc Anticancer Drugs Product Introduction
- 7.5.4 Pfizer Inc Response to COVID-19 and Related Developments
- 7.6 Amgen Inc
- 7.6.1 Amgen Inc Business Overview
- 7.6.2 Amgen Inc Anticancer Drugs Quarterly Production and Revenue, 2020
- 7.6.3 Amgen Inc Anticancer Drugs Product Introduction
- 7.6.4 Amgen Inc Response to COVID-19 and Related Developments
- 7.7 Bayer AG
- 7.7.1 Bayer AG Business Overview
- 7.7.2 Bayer AG Anticancer Drugs Quarterly Production and Revenue, 2020
- 7.7.3 Bayer AG Anticancer Drugs Product Introduction
- 7.7.4 Bayer AG Response to COVID-19 and Related Developments
- 7.8 AstraZeneca
- 7.8.1 AstraZeneca Business Overview
- 7.8.2 AstraZeneca Anticancer Drugs Quarterly Production and Revenue, 2020
- 7.8.3 AstraZeneca Anticancer Drugs Product Introduction
- 7.8.4 AstraZeneca Response to COVID-19 and Related Developments
- 7.9 Takeda Pharmaceutical Company Limited
- 7.9.1 Takeda Pharmaceutical Company Limited Business Overview
- 7.9.2 Takeda Pharmaceutical Company Limited Anticancer Drugs Quarterly Production and Revenue, 2020
- 7.9.3 Takeda Pharmaceutical Company Limited Anticancer Drugs Product Introduction
- 7.9.4 Takeda Pharmaceutical Company Limited Response to COVID-19 and Related Developments
- 7.10 Merck & Co.
- 7.10.1 Merck & Co. Business Overview
- 7.10.2 Merck & Co. Anticancer Drugs Quarterly Production and Revenue, 2020
- 7.10.3 Merck & Co. Anticancer Drugs Product Introduction
- 7.10.4 Merck & Co. Response to COVID-19 and Related Developments
8 Supply Chain and Sales Channels Analysis
- 8.1 Anticancer Drugs Supply Chain Analysis
- 8.1.1 Anticancer Drugs Supply Chain Analysis
- 8.1.2 Covid-19 Impact on Anticancer Drugs Supply Chain
- 8.2 Distribution Channels Analysis
- 8.2.1 Anticancer Drugs Distribution Channels
- 8.2.2 Covid-19 Impact on Anticancer Drugs Distribution Channels
- 8.2.3 Anticancer Drugs Distributors
- 8.3 Anticancer Drugs Customers
9 Key Findings
10 Appendix
- 10.1 About Us
Description
This report covers market size and forecasts of Anticancer Drugs, including the following market information:
Global Anticancer Drugs Market Size, 2019-2021, and 2020 (quarterly data), (US$ Million) & (MT)
Global Anticancer Drugs Market Size by Type and by Application, 2019-2021, and 2020 (quarterly data), (US$ Million) & (MT)
Global Anticancer Drugs Market Size by Region (and Key Countries), 2019-2021, and 2020 (quarterly data), (US$ Million) & (MT)
Global Anticancer Drugs Market Size by Company, 2019- 2020 (quarterly data), (US$ Million) & (MT)
Key market players
Major competitors identified in this market include F. Hoffmann-La Roche Ltd, Eli Lilly and Company, CELGENE CORPORATION, Novartis AG, Pfizer Inc, Amgen Inc, Bayer AG, AstraZeneca, Takeda Pharmaceutical Company Limited, Merck & Co., etc.
Based on the Region:
Asia-Pacific (China, Japan, South Korea, India and ASEAN)
North America (US and Canada)
Europe (Germany, France, UK and Italy)
Rest of World (Latin America, Middle East & Africa)
Based on the Type:
Cytotoxic Drugs (Alkylating Agents, and Antimetabolites)
Targeted Drugs (Monoclonal Antibodies and Tyrosine Kinase Inhibitors)
Hormonal Drugs
Based on the Application:
Lung Cancer
Breast Cancer
Leukemia
Colorectal Cancer